• FirefoxUpgrade to the new Firefox »
  •  Dow Down1.45% Nasdaq Down1.03%

    More On 009420.KS

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    HanAll Biopharma Co., Ltd. (009420.KS)

    -KSC
    4,040.00 Up 50.00(1.25%) Jan 30, 1:00AM EST
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Net Income 244,000   242,000   528,000   (12,708,000)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation569,000  558,000  560,000  546,000  
    Adjustments To Net Income -   -   -   -  
    Changes In Accounts Receivables(1,859,000)(1,693,000)(1,754,000)2,970,000  
    Changes In Liabilities -   -   -   -  
    Changes In Inventories244,000  (711,000)2,328,000  (1,496,000)
    Changes In Other Operating Activities150,000  (1,011,000)(3,556,000)(417,000)
    Total Cash Flow From Operating Activities (1,674,000) (718,000) (1,450,000) (3,150,000)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(471,000)(237,000)(388,000)(1,995,000)
    Investments -   -   -   -  
    Other Cash flows from Investing Activities -   -   -   -  
    Total Cash Flows From Investing Activities 276,000   1,063,000   (1,095,000) 6,046,000  
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -   -  
    Sale Purchase of Stock -   -   -   -  
    Net Borrowings -   -   -   -  
    Other Cash Flows from Financing Activities742,000  1,300,000  (707,000)8,005,000  
    Total Cash Flows From Financing Activities 870,000   502,000   (1,080,000) (717,000)
    Effect Of Exchange Rate Changes14,000  (41,000)24,000  (78,000)
    Change In Cash and Cash Equivalents (514,000) 806,000   (3,601,000) 2,101,000  

    Currency in KRW.